Critical role of pathology and laboratory medicine in the conversation surrounding access to healthcare

  title={Critical role of pathology and laboratory medicine in the conversation surrounding access to healthcare},
  author={Cullen M. Lilley and Kamran M. Mirza},
  journal={Journal of Medical Ethics},
Pathology and laboratory medicine are a key component of a patient’s healthcare. From academic care centres, community hospitals, to clinics across the country, pathology data are a crucial component of patient care. But for much of the modern era, pathology and laboratory medicine have been absent from health policy conversations. Though select members in the field have advocated for an enhanced presence of these specialists in policy conversations, little work has been done to thoroughly… 



Improving Pathologists' Communication Skills.

  • S. Dintzis
  • Medicine, Psychology
    AMA journal of ethics
  • 2016
Providing communication training can help create reliable communication pathways that anticipate and address potential barriers and errors before they happen and establish best practice procedures for effective pathology communication.

When Pathology and Laboratory Medicine Becomes a Commodity and Health Care Becomes Both Its Customer and Owner

It is documents that the Calgary Laboratory Services’ (CLS) model is presently expanding across Canada, updates and analyzes recent changes in Alberta, and suggests lessons learned from the model’s evolution.

Ethical considerations for modern molecular pathology

It is recommended that pathologists take responsibility for the adequate use of molecular analyses and be fully aware and capable of dealing with the diverse, complex, and challenging aspects of tumor DNA sequencing, including its ethical issues.

Reducing Diagnostic Errors Worldwide Through Diagnostic Management Teams

Examining the situation in the United States and Italy, this review presents an opportunity for reducing diagnostic error and increasing the efficiency of diagnostic testing worldwide.

The road ahead in genetics and genomics

To celebrate the first 20 years of Nature Reviews Genetics, 12 leading scientists take stock of the current state of play and emphasize the work that remains to be done over the next few years so that, ultimately, the benefits of genetic and genomic research can be felt by everyone.

Ethical Considerations about EHR-Mediated Results Disclosure and Pathology Information Presented via Patient Portals.

Electronic health records (EHR) now include patient portals where patients can obtain clinical reports, including notes, radiology reports, and laboratory/anatomic pathology results, and ethical questions about patient access to test results online are discussed.

Addressing social determinants of noncommunicable diseases in primary care: a systematic review

How primary care organizations assess and subsequently act upon the social determinants of noncommunicable diseases in their local populations is explored to help policy-makers to consider suitable approaches for assessing and addressing social determinant of health in their domestic context.

Equitable Participation in Biobanks: The Risks and Benefits of a “Dynamic Consent” Approach

Dynamic Consent, which is a digital decision-support tool, could improve participants' recruitment to, and engagement with, biobanks over time and help to overcome some of the barriers to participation, but there are also risks that it may deepen the "digital divide" by favoring those with knowledge and access to digital technologies.

The Effect of Large-scale Health Coverage Expansions in Wealthy Nations on Society-Wide Healthcare Utilization

It is concluded that in wealthy nations, large-scale coverage expansions need not cause overall utilization to surge if provider supply is controlled, and such reforms could redirect care towards patients who most need it.

Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses

A high degree of analytic consensus is found for the fiscal feasibility of a single-payer approach in the US, and changes in total costs standardized to percentage of contemporaneous healthcare spending are measured.